What the FDA labels say about taking them together
Epinephrine and taliglucerase alfa
Taliglucerase alfa's FDA label of December 29, 2025 names epinephrine in its boxed warning section; the epinephrine labels PlainMeds reads (4) do not name taliglucerase alfa.
Check it at the source: the epinephrine FDA label on DailyMed (effective July 13, 2026, A-S Medication Solutions); the taliglucerase alfa FDA label on DailyMed (effective December 29, 2025, Pfizer Laboratories Div Pfizer Inc).
What does the epinephrine label say about taliglucerase alfa?
Epinephrine's label (effective July 13, 2026) and its 3 other brand-application labels do not name taliglucerase alfa in these sections. A label lists what its studies and reports found; it is not a complete list.
Source: FDA drug label (Epinephrine), A-S Medication Solutions, effective July 13, 2026 (SPL set 6e811e28-0199-4df7-a916-5940c632401d), via openFDA; the full label on DailyMed
What does the taliglucerase alfa label say about epinephrine?
Taliglucerase alfa label, boxed warningIf a severe hypersensitivity reaction (e.g., anaphylaxis) occurs, discontinue ELELYSO and immediately initiate appropriate medical treatment, including use of epinephrine.
Source: FDA drug label (ELELYSO), Pfizer Laboratories Div Pfizer Inc, effective December 29, 2025 (SPL set fa3cbd5d-677c-4b19-9032-d9182cb69a83), via openFDA; the full label on DailyMed
These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.
Both medicines on the record
| Epinephrine | Taliglucerase alfa | |
|---|---|---|
| Labeled for | Asthma | n/a |
| Boxed warning | No | Yes |
| Pharmacy cost (NADAC) | $123.51 per unit 0.15 mg auto-injct | n/a |
| Shortage now | A presentation being discontinued | No current entry |
Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)
What next?
- Check more medicines together
- up to five at once